Parents who advised daughter against chemotherapy warned over inquest behaviour
Paloma Shemirani, 23, collapsed on July 19 last year and was taken to Royal Sussex County Hospital where she died five days later. She had earlier declined treatment for non-Hodgkin lymphoma.
Her mother, Kay 'Kate' Shemirani, a prominent online conspiracy theorist and her father, Dr Faramarz Shemirani, who is 'sympathetic' to his ex-wife's views, believe medical professionals are to blame for their daughter's death.
Coroner Catherine Wood, presiding over the inquest at Kent and Medway Coroner's Court in Maidstone, left the court due to the behaviour of Miss Shemirani's parents on Tuesday afternoon.
The inquest, which was originally scheduled to conclude on Wednesday, had been extended as the evidence and questioning of witnesses had taken longer than anticipated.
On Tuesday, Mrs Shemirani, who was struck off as a nurse in 2021 after spreading harmful misinformation about Covid-19, was cross-examined by Dr Shemirani.
Questioning broke down when Dr Shemirani, who is understood to have a PhD in computational fluid dynamics, tried to ask his ex-wife's opinion of medical evidence which she would then try to answer, despite warnings from the coroner.
'Mrs Shemirani, I've told you not to speak, I'll find you in contempt if you keep on speaking now,' the coroner said.
'Confine (yourself) to asking questions of this witness as a witness of fact,' she told Dr Shemirani.
As Dr Shemirani argued back through his video-link, the coroner said: 'Dr Shemirani, challenge me by judicial review later' before trying to move on.
'Of course I will, of course I will,' he replied.
Later, Dr Shemirani once again tried to ask questions which had already been ruled irrelevant by the coroner.
'I'm going to rise for a few minutes because I'm finding it incredibly difficult to keep you on track,' said Ms Wood.
Dr Shemirani continued to speak until the coroner shouted 'Dr Shemirani, listen'.
'Your behaviour has been bordering on contemptuous to the court – when I make a ruling on something you cannot come back,' she added.
Mrs Shemirani also accused osteopath Nick Gosset of lying under oath earlier in the inquest.
Mr Gosset treated Miss Shemirani the day she collapsed and said she had appeared to be in the 'last stages of a very difficult disease'.
He told the court that when he inspected her, he could feel lumps in her right shoulder going all the way up into her neck, which he identified as lymphoid mass and that he 'had never seen anything like it' in 43 years of practice.
Mr Gosset told the court: 'It was obvious to me that I was not the right person to be helping her, normally you see a patient like that, you would refer her (to a GP).
'Any referral was refused – when I suggested that the proper avenue of approach was through a normal, medical channel she dismissed it.
On Tuesday, Paloma's mother said 'his statement under oath is completely opposed with the truth' and has argued her daughter was healthy the day she collapsed.
The inquest continues on Wednesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Health warning issued as new virus detected in UK for the first time
The Oropouche virus, a tropical malaria-like disease, has been detected in Britain for the first time. The UK Health Security Agency reported three cases between January and June this year, all in individuals who had returned from Brazil. Typically found in South America, the virus can cause severe symptoms including high fever, headaches, and in rare instances, meningitis and death. It is primarily spread through bites from midges and some mosquitos, with concerns about sexual and mother-to-baby transmission. There is no cure, but preventative measures such as using insect repellent with 50 per cent DEET and protective clothing are advised for travellers to affected areas.
South Wales Argus
2 hours ago
- South Wales Argus
Mounjaro prices double as weight loss jab popularity soars
US-based Eli Lilly says a 5mg dose will nearly double from £92 to £180 from September 1, while a 15mg pen will rise from £122 to £330. A Lilly spokesperson said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from 1 September to address pricing inconsistencies compared to other developed countries, including in Europe. We have reached an agreement with the NHS to ensure continued supply and patient access." The statement continues: 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability." More than 1.5 million people in the UK are believed to be using weight-loss medication each month, with most buying the jabs from private pharmacies. Mounjaro users report surprising side effect - pharmacists share their tips — Bucks Free Press (@bucksfreepress) August 8, 2025 This comes as the Government has joined forces with Eli Lilly in a bid to tackle obesity. The move could see patients accessing care at pharmacies or by using online platforms. The £85 million programme from Eli Lilly and the Department for Science, Innovation and Technology (DSIT) has been designed to look at how obese patients can access weight management care more easily. This includes through community services, in pharmacies and online. Using these tools, eligible patients could be treated 'in a matter of months', according to Health Secretary Wes Streeting. Under the agreement, the Government will contribute up to £50 million in UK-wide investment. Meanwhile, Eli Lilly will back the programme with £35 million, and NHS organisations will be able to apply for a share of the funding. Recommended reading: Mounjaro warning as pens ruined by heatwave temperatures This comes as users are risking having to throw away perfectly good Mounjaro pens as they have overheated in the recent heatwave. Improper storage of Ozempic, Wegovy and Mounjaro during a heatwave could destroy the active ingredient in these jabs, potentially wiping out their effects entirely, even if the medication looks completely normal. 'We recommend treating your weight-loss pen the same way you'd treat insulin or any critical medication,' says Danielle Brightman, Clinical Director at Numan. 'When in doubt, don't risk it. Speak to a healthcare professional and arrange a replacement.' 8 tips to protect Mounjaro and other weight-loss injections during hot weather Use a medical-grade cool bag. Transport your pen in a proper, insulated container designed for sensitive medications. Don't use improvised ice packs that might freeze the pen by accident. Never leave your pen in hot places. Even 10 minutes in a parked car or on a sunny kitchen counter could expose it to damaging heat if out of its delivery packaging or unrefrigerated. Always check the environment before setting it down. Store below 30°C once in use. Once opened and if not refrigerated, keep your pen in a shaded, ventilated area, away from heat sources, windows, and radiators. If you live in a flat or home without air conditioning, keep the pen in a bedroom or hallway that doesn't heat up from direct sun. Avoid storing near exterior walls if the property retains heat. Follow the usage timeline carefully. The storage instructions between medications. Wegovy after first use can last 6 weeks below 30 degrees then needs to be disposed of, whereas Mounjaro has a shorter time of 30 days below 30 degrees before needing to be disposed of. Stick to that timeframe, and if you're unsure whether it's still safe, consult your provider. Use a fridge thermometer at home. Fridge temperatures can fluctuate, especially in older models or over-packed shelves. A simple digital fridge thermometer can help ensure your pen is always stored between 2–8°C before first use. Planning to travel? Use airline-friendly cooling cases. If you're flying or taking long journeys, consider TSA-approved insulated medication pouches with cooling gel packs. Always store the pen in carry-on luggage, not checked baggage, as cargo holds can get hot or cold. Set storage reminders on your phone. If you're prone to forgetting where you left your pen, set daily reminders to check if it's stored properly, especially during heatwaves or while travelling. Don't store near appliances or steam sources. Keep pens away from kettles, toasters, ovens, dishwashers, and anywhere that might experience sudden heat or humidity, especially in small kitchens or shared spaces. Injections like Ozempic, Wegovy, and Mounjaro are now widely used across the UK for appetite control and sustainable weight management. But despite their growing popularity and increasing availability now through the NHS, most patients don't realise the strict temperature guidelines that must be followed to keep these drugs effective. 'We speak to patients every day who are using GLP-1s for the first time,' says Danielle. 'With temperatures set to soar again this summer, it's crucial we raise awareness about safe medication storage. Heat damage isn't always obvious, but it can have a huge impact on effectiveness and safety."
The Independent
2 hours ago
- The Independent
What is sloth fever? Symptoms and advice after UK Oropouche virus cases
The UK's health security watchdog has issued an urgent warning as cases of a deadly malaria-like ' sloth virus ' were found in Britain for the first time. Three cases of Oropouche virus, which naturally occurs in sloths, primates and birds, were reported across Britain between January and June 2025, according to the UK Health Security Agency (UKHSA. All three cases were in people who had returned to the UK after travelling abroad to Brazil after a surge of virus infections across the region. In some cases, the tropical disease can lead to meningitis and death, with two people in Brazil dying from the virus over the last few years. Here, The Independent takes a look at Oropouche virus symptoms and what experts say to do if you think you have the disease. Signs and symptoms of Oropouche virus disease fever headache joint pain muscle aches chills nausea and vomiting rash sensitivity to light dizziness pain behind the eyes How is it spread and how to avoid it? The lesser-known infection is spread through bites from small midges and some mosquitos, and can also be transmitted through sexual activity. It is also feared the disease can be spread from mothers to babies during pregnancy, which can cause congenital or developmental abnormalities, according to the UKHSA. There is no cure, but there are preventative measures travellers can take like wearing long-sleeved clothing and using insect repellent to ward off midges. These insect repellents need to be 50 per cent DEET—the active ingredient which repels pests like midges and mosquitos. Other measures include staying in places with air conditioning or window screens with fine mesh to keep out midges and using insecticide-treated fine mesh bed nets. What is the cause and how is it treated? Oropouche virus is an RNA virus that belongs to the Simbu serogroup of the genus Orthobunyavirus in the family Peribunyaviridae, according to the US Centers for Disease Control and Prevention. Treatment is about managing symptoms: rest, drink plenty of fluids, and take paracetamol or other over-the-counter meds to ease fever and pain, the UKHSA says. If you develop severe symptoms, especially anything that might suggest brain involvement (like severe headache, confusion, or neck stiffness), the agency urges people to seek immediate medical help.
